Labcorp (LH): analysis and statistics
Return, volatility, Sharpe ratio and risk for Labcorp, a component of the S&P 500 in the Health Care. Data as of 2026-10-29.
| Last close price | $360.25 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +23.36% |
| Total return over period | +87.10% |
| Annualized volatility | 23.27% |
| Period volatility | 40.19% |
| Period T-bill | 12.40% |
| Sharpe ratio | 1.86 |
| Sortino ratio | 2.83 |
| Max drawdown | -17.36% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.10% |
| Correlation with the S&P 500 | 0.33 |
| Period range | $188.24 – $360.25 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Labcorp (LH) has posted an annualized return of +23.36% with annual volatility of 23.27%, a Sharpe ratio of 1.86. Its worst stretch (max drawdown from a peak) was -17.36%. Its correlation with the S&P 500 is 0.33, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how LH would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with LH →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Labcorp (LH) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio